Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Queen's University

$70,000.00

Novel materials and methods for protein and cell bioencapsulation

FY 2015-16

Summary
Bioencapsulation involves packaging tissues, enzymes, and therapeutic biopharmaceuticals, into a polymeric matrix. The resulting structures can protect, then control release of a fragile drug such as insulin. As example, I am conducting research on oral delivery of insulin, where either released insulin or the nanoencapsulated form is absorbed from the intestinal tract. The benefits to Canadian diabetics are enormous in terms of patient compliance and comfort, but the scientific and engineering challenges are also considerable. In particular, the acidic, enzyme-rich stomach and intestinal track are major barriers to insulin delivery. The objective of my research in the natural sciences and engineering is to focus on insulin delivery using novel approaches in encapsulation methods and materials. The proposal is built around four objectives, interrelated through insulin delivery. The first objective is to achieve long term (weeks) sustained delivery of low insulin levels from microparticles, then ultimately from microparticles embedded within natural polymer foams or films. The long-term goal is to design dressings for burn injuries. The second objective is to encapsulate human islet cells with fabricated cell matrix protein scaffold, all within a polymeric particle. Canada is a leader in islet implantation therapies, and this initiative can contribute to the advancement of diabetes treatment. The third and fourth objectives are to chemically modify natural polymers providing novel biomaterials that do not exist in nature, and have not been previously synthesized. The intent is to use the new biomaterials for drug delivery applications, and in diagnostics and bioseparations. This research provides exciting opportunity for training of highly qualified personnel, since it is multi-disciplinary, spanning chemical/biochemical/biomedical engineering with emphasis on new advanced biopolymeric materials and structures, and nanotechnology, supported through appropriate experimental methods and instrumentation. Trained researchers will advance to careers in pharmaceuticals, biomedical devices, advanced materials, biotechnology, and academia - areas of strategic importance to Canada.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
204794-2011
Name nom
Neufeld, Ronald
Department département
Chemical Engineering
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2011
Award amount
70000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
5
Nb partie
5
Application title
Novel materials and methods for protein and cell bioencapsulation
Keyword
NSERC
Application summary
Bioencapsulation involves packaging tissues, enzymes, and therapeutic biopharmaceuticals, into a polymeric matrix. The resulting structures can protect, then control release of a fragile drug such as insulin. As example, I am conducting research on oral delivery of insulin, where either released insulin or the nanoencapsulated form is absorbed from the intestinal tract. The benefits to Canadian diabetics are enormous in terms of patient compliance and comfort, but the scientific and engineering challenges are also considerable. In particular, the acidic, enzyme-rich stomach and intestinal track are major barriers to insulin delivery. The objective of my research in the natural sciences and engineering is to focus on insulin delivery using novel approaches in encapsulation methods and materials. The proposal is built around four objectives, interrelated through insulin delivery. The first objective is to achieve long term (weeks) sustained delivery of low insulin levels from microparticles, then ultimately from microparticles embedded within natural polymer foams or films. The long-term goal is to design dressings for burn injuries. The second objective is to encapsulate human islet cells with fabricated cell matrix protein scaffold, all within a polymeric particle. Canada is a leader in islet implantation therapies, and this initiative can contribute to the advancement of diabetes treatment. The third and fourth objectives are to chemically modify natural polymers providing novel biomaterials that do not exist in nature, and have not been previously synthesized. The intent is to use the new biomaterials for drug delivery applications, and in diagnostics and bioseparations. This research provides exciting opportunity for training of highly qualified personnel, since it is multi-disciplinary, spanning chemical/biochemical/biomedical engineering with emphasis on new advanced biopolymeric materials and structures, and nanotechnology, supported through appropriate experimental methods and instrumentation. Trained researchers will advance to careers in pharmaceuticals, biomedical devices, advanced materials, biotechnology, and academia - areas of strategic importance to Canada.